Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | DTP, DTaP, or DT | Hepatitis B | MMR | Polio | Varicella 1 dose | Varicella 2 dose |
|---|---|---|---|---|---|---|
| 2011/12 | 95% | 96.4% | 94.7% | 95.3% | 96.1% | 93.7% |
| 2012/13 | 94.6% | 95.7% | 94.1% | 94.7% | 96.2% | 93.2% |
| 2013/14 | 94.3% | 95.5% | 94% | 94.4% | 96.2% | 92.8% |
| 2014/15 | 94.3% | 95.3% | 94% | 94.4% | 95.1% | 93.8% |
| 2015/16 | 94.7% | 95.8% | 94.7% | 94.7% | 96% | 94.3% |
| 2016/17 | 95.2% | 96% | 95% | 95.2% | 97.5% | 94.2% |
| 2017/18 | 95.2% | 96.1% | 95% | 95.1% | 97.1% | 94.4% |
| 2018/19 | 94.9% | 95.8% | 94.7% | 94.7% | 96.4% | 94.3% |
| 2019/20 | 94.9% | 96.1% | 95.2% | 95% | 94.1% | 94.8% |
| 2020/21 | 93.6% | 94.6% | 93.9% | 93.9% | 94.8% | 93.5% |
| 2021/22 | 92.7% | 94.1% | 93% | 93.1% | 94.6% | 92.7% |
| 2022/23 | 92.7% | 94.3% | 93.1% | 93.1% | 94.2% | 92.8% |
| 2023/24 | 92.3% | 93.9% | 92.7% | 92.7% | 93.7% | 92.3% |
| 2024/25 | 92.1% | 94% | 92.5% | 92.5% | 94% | 92.1% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Zoomable Statistic: Select the range in the chart you want to zoom in on.
Loading statistic...
Download
Source
Source
Release date
July 2025
More information
Region
United States
Survey time period
2011 to 2025
Age group
19 to 35 months
Citation formats
